The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management
| Autor: | Teresa Ocaña, Maria Liz Leoz, Francesc Balaguer, Sabela Carballal, Leticia Moreira |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oncology
medicine.medical_specialty Pathology congenital hereditary and neonatal diseases and abnormalities MUTYH Colorectal cancer Genetic counseling colorectal cancer Disease Review Germline Familial adenomatous polyposis Germline mutation Internal medicine familial adenomatous polyposis Genetics medicine neoplasms Genetics (clinical) business.industry medicine.disease digestive system diseases APC Clinical Practice MAP business |
| Zdroj: | The Application of Clinical Genetics |
| ISSN: | 1178-704X |
| Popis: | Familial adenomatous polyposis (FAP) is an inherited disorder that represents the most common gastrointestinal polyposis syndrome. Germline mutations in the APC gene were initially identified as responsible for FAP, and later, several studies have also implicated the MUTYH gene as responsible for this disease, usually referred to as MUTYH-associated polyposis (MAP). FAP and MAP are characterized by the early onset of multiple adenomatous colorectal polyps, a high lifetime risk of colorectal cancer (CRC), and in some patients the development of extracolonic manifestations. The goal of colorectal management in these patients is to prevent CRC mortality through endoscopic and surgical approaches. Individuals with FAP and their relatives should receive appropriate genetic counseling and join surveillance programs when indicated. This review is focused on the description of the main clinical and genetic aspects of FAP associated with germline APC mutations and MAP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|